Dr. David Samadi Addresses Risk Among Diabetes Drugs And Bladder Cancer

Studies have found that drugs designed to help patients with type 2 diabetes that control blood sugar levels also increases the risk of bladder cancer. According to the Chairman of Urology at Lenox Hill Hospital, Dr. David Samadi, diabetes patients should have a consultation with a urologist to discuss these concerns.

Experts Reviewed Statistics

Canadian researchers investigated the relationship between taking the drug, Pioglitazone, and a number of bladder cancer cases. The results of the large study show that the intake of pioglitazone is associated with an increased risk of bladder cancer.

The experts examined data from 145,806 patients from a UK research database. The patients had taken the drug between the years 2000 and 2013. In 2000, pioglitazone was launched with another drug. The follow-up examinations ended in July 2014, and overall, a bladder cancer disease was detected in 622 subjects. But Dr. David Samadi says the risk increases with the duration of use and the dose of the drug, and there have been no such increased risks with other diabetes drugs. Diabetes could lead to blindness, stroke, kidney failure and amputation of the limbs.

Dr. Samadi says bladder cancer can go unnoticed for a long time. As long as the tumors remain superficially on the bladder wall, they are usually easy to remove. In advanced cancer, new procedures can dramatically improve the possibilities of treatment.

The Warning Signs Of Bladder Cancer

Bladder cancer, is a malignant tumor in the urinary bladder. It can also affect the renal pelvis, ureter and urethra, and men are nearly three times more likely to be affected by the disease.

• Bladder irritation or painful urination can quickly be confused with signs of cystitis

• Another warning sign is blood in the urine. But only larger amounts of blood lead to a visible discoloration of the excretions.

• If you notice a reddish or brownish discoloration, you should consult a urologist

If bladder cancer is suspected, Dr. Samadi performs a cystoscopy that provides an inside view of the bladder and urinary tract. If he discovers suspicious signs, he will take tissue samples.

Dr. Samadi says even when it goes unnoticed, most bladder carcinomas are still detected in early stages. If the tumor lies superficially on the bladder wall and has not grown into the muscle layer, it can usually be removed with a minimally invasive procedure.

Dr. David Samadi is a board certified urologist. He treats conditions and diseases such as problems with the bladder, urethra, kidneys, prostate, testes, and other disorders. He is internationally recognized as a leader, and top urologist, and has been voted Top Doctor for several consecutive years.

Dr. Samadi is a native of New York, and graduated medical school from Stony Brook University. He completed his residency at local New York hospitals (Montefiore Hospital/Albert Einstein Hospital), and a oncology fellowship at Memorial Sloan Kettering Cancer Center.

For details: prostatecancer911.com/david-samadi/

Leave a Reply

Your email address will not be published. Required fields are marked *